MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 216 filers reported holding MEDIVATION INC in Q4 2013. The put-call ratio across all filers is 1.03 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $20,448,000 | +22.5% | 339,100 | -6.6% | 0.03% | +22.2% |
| Q1 2016 | $16,691,000 | -5.0% | 363,000 | -0.2% | 0.03% | -3.6% |
| Q4 2015 | $17,576,000 | +7.9% | 363,600 | -5.2% | 0.03% | 0.0% |
| Q3 2015 | $16,295,000 | -31.7% | 383,400 | +83.4% | 0.03% | -22.2% |
| Q2 2015 | $23,868,000 | +4.1% | 209,000 | -4.6% | 0.04% | +12.5% |
| Q1 2015 | $22,934,000 | 0.0% | 219,000 | 0.0% | 0.03% | 0.0% |
| Q4 2014 | $22,934,000 | -20.8% | 219,000 | -25.2% | 0.03% | -20.0% |
| Q3 2014 | $28,939,000 | +106.2% | 292,700 | +60.8% | 0.04% | +110.5% |
| Q2 2014 | $14,033,000 | +190.0% | 182,064 | +127.1% | 0.02% | +171.4% |
| Q1 2014 | $4,839,000 | +22.7% | 80,154 | +30.3% | 0.01% | +16.7% |
| Q4 2013 | $3,945,000 | -55.3% | 61,500 | -58.3% | 0.01% | -62.5% |
| Q3 2013 | $8,832,000 | +23.2% | 147,344 | +1.1% | 0.02% | +14.3% |
| Q2 2013 | $7,170,000 | – | 145,738 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |